Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy L Weigel

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Oncogene|September 20, 2018
Inositol polyphosphate 4-phosphatase type II regulation of androgen receptor activityManqi Zhang, Egla Suarez, Judy L Vasquez, et al.
Molecular and Cellular Biology|January 20, 2005
c-Jun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor alphaHarish Srinivas, Denise M Juroske, Shailaja Kalyankrishna, et al.
Cancer Research|January 13, 2011
Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancerMyles C Hodgson, Long-jiang Shao, Anna Frolov, et al.
Biochemistry|June 18, 2003
Novel phosphorylation target in the serum response factor MADS box regulates alpha-actin transcriptionDinakar Iyer, Narasimhaswamy Belaguli, Martin Flück, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2004
Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cellsNarasimha Swamy, Tai C Chen, Sara Peleg, et al.
The Journal of Clinical Endocrinology and Metabolism|December 8, 2004
A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer riskIrina U Agoulnik, Xiao-Wen Tong, Dagmar-C Fischer, et al.
Journal of Cellular Biochemistry|January 28, 2006
Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubilityMarco Marcelli, David L Stenoien, Adam T Szafran, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|May 25, 2012
A standards-based, peer-reviewed teaching award to enhance a medical school's teaching environment and inform the promotions processNancy S Searle, Cayla R Teal, Boyd F Richards, et al.
International Journal of Oncology|November 16, 2012
Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expressionSuqin He, Chaohua Zhang, Ayesha A Shafi, et al.
Oncotarget|September 18, 2015
Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cellsAyesha A Shafi, Vasanta Putluri, James M Arnold, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Oncogene|September 20, 2018
Inositol polyphosphate 4-phosphatase type II regulation of androgen receptor activityManqi Zhang, Egla Suarez, Judy L Vasquez, et al.
Molecular and Cellular Biology|January 20, 2005
c-Jun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor alphaHarish Srinivas, Denise M Juroske, Shailaja Kalyankrishna, et al.
Cancer Research|January 13, 2011
Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancerMyles C Hodgson, Long-jiang Shao, Anna Frolov, et al.
Biochemistry|June 18, 2003
Novel phosphorylation target in the serum response factor MADS box regulates alpha-actin transcriptionDinakar Iyer, Narasimhaswamy Belaguli, Martin Flück, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2004
Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cellsNarasimha Swamy, Tai C Chen, Sara Peleg, et al.
The Journal of Clinical Endocrinology and Metabolism|December 8, 2004
A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer riskIrina U Agoulnik, Xiao-Wen Tong, Dagmar-C Fischer, et al.
Journal of Cellular Biochemistry|January 28, 2006
Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubilityMarco Marcelli, David L Stenoien, Adam T Szafran, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|May 25, 2012
A standards-based, peer-reviewed teaching award to enhance a medical school's teaching environment and inform the promotions processNancy S Searle, Cayla R Teal, Boyd F Richards, et al.
International Journal of Oncology|November 16, 2012
Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expressionSuqin He, Chaohua Zhang, Ayesha A Shafi, et al.
Oncotarget|September 18, 2015
Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cellsAyesha A Shafi, Vasanta Putluri, James M Arnold, et al.
Pageof 8